LPL and obesity due to melanocortin 4 receptor deficiency: The anti-obesity properties of resveratrol may be connected to its anti-diabetic properties [13,14], with decreased action of lipogenic enzymes (acetyl-CoA carboxylase, glucose-6-P-dehydrogenase, and lipoprotein liPase) [92].